| Quarter | Score |
|---|---|
| 2022-Q4 | 49.2 |
| 2023-Q1 | 49.1 |
| 2023-Q3 | 50.1 |
| 2023-Q4 | 36.6 |
| 2024-Q1 | 59.7 |
| 2024-Q2 | 51.3 |
| 2024-Q3 | 91.4 |
| 2024-Q4 | 87.3 |
| 2025-Q1 | 87.2 |
| 2025-Q2 | 87.1 |
| 2025-Q3 | 87.2 |
| 2025-Q4 | 87.2 |
| 2026-Q1 | 86.4 |
| 2026-Q2 | 86.6 |
Funds reducing exposure or consensus momentum fading
Trading 21.7% below funds' estimated purchase price
2 of 18 tracked funds hold BN. Avg conviction: 6.3%. Net trimming. First tracked at $47.34 (current -21.7% vs tracked).
Pershing Square has 12.6% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Pershing Square | 12.6% | Reduce |
| Citadel Advisors | 0.0% | Reduce |